Fair Richard A. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Aug 23, 2019
Insider Transaction Report
Form 4
Fair Richard A.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2019-08-21$0.99/sh+20,000$19,780→ 26,561 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9855 to $0.995, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Includes 6,561 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan.